Selected research
Industry Research
Acrivastine Capsules Industry Research Report 2026
Market perspective
The global Acrivastine Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Acrivastine Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Acrivastine Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Acrivastine Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Acrivastine Capsules include Actient Pharmaceuticals, Benadryl, Brown & Burk UK, McNeil Laboratories, The Wellcome Foundation and Chongqing Huapont Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Acrivastine Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Acrivastine Capsules Market by Company
Actient Pharmaceuticals
Benadryl
Brown & Burk UK
McNeil Laboratories
The Wellcome Foundation
Chongqing Huapont Pharmaceutical
Acrivastine Capsules Segment by Type
24 Capsules/Box
20 Capsules/Box
12 Capsules/Box
Acrivastine Capsules Segment by Application
Hospital
Clinic
Acrivastine Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acrivastine Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acrivastine Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acrivastine Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Acrivastine Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Acrivastine Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Acrivastine Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 24 Capsules/Box
- 20 Capsules/Box
- 12 Capsules/Box
Applications
- Hospital
- Clinic
Companies covered
- Actient Pharmaceuticals
- Benadryl
- Brown & Burk UK
- McNeil Laboratories
- The Wellcome Foundation
- Chongqing Huapont Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Acrivastine Capsules Market Size (2021-2032)
- 2.2.2 Global Acrivastine Capsules Sales (2021-2032)
- 2.2.3 Global Acrivastine Capsules Market Average Price (2021-2032)
- 2.3 Acrivastine Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 24 Capsules/Box
- 2.3.3 20 Capsules/Box
- 2.3.4 12 Capsules/Box
- 2.4 Acrivastine Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Acrivastine Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Acrivastine Capsules Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Acrivastine Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Acrivastine Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Acrivastine Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Acrivastine Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Acrivastine Capsules, Product Type & Application
- 3.8 Global Manufacturers of Acrivastine Capsules, Established Date
- 3.9 Global Acrivastine Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actient Pharmaceuticals
- 4.1.1 Actient Pharmaceuticals Company Information
- 4.1.2 Actient Pharmaceuticals Business Overview
- 4.1.3 Actient Pharmaceuticals Acrivastine Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actient Pharmaceuticals Acrivastine Capsules Product Portfolio
- 4.1.5 Actient Pharmaceuticals Recent Developments
- 4.2 Benadryl
- 4.2.1 Benadryl Company Information
- 4.2.2 Benadryl Business Overview
- 4.2.3 Benadryl Acrivastine Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Benadryl Acrivastine Capsules Product Portfolio
- 4.2.5 Benadryl Recent Developments
- 4.3 Brown & Burk UK
- 4.3.1 Brown & Burk UK Company Information
- 4.3.2 Brown & Burk UK Business Overview
- 4.3.3 Brown & Burk UK Acrivastine Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Brown & Burk UK Acrivastine Capsules Product Portfolio
- 4.3.5 Brown & Burk UK Recent Developments
- 4.4 McNeil Laboratories
- 4.4.1 McNeil Laboratories Company Information
- 4.4.2 McNeil Laboratories Business Overview
- 4.4.3 McNeil Laboratories Acrivastine Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 McNeil Laboratories Acrivastine Capsules Product Portfolio
- 4.4.5 McNeil Laboratories Recent Developments
- 4.5 The Wellcome Foundation
- 4.5.1 The Wellcome Foundation Company Information
- 4.5.2 The Wellcome Foundation Business Overview
- 4.5.3 The Wellcome Foundation Acrivastine Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 The Wellcome Foundation Acrivastine Capsules Product Portfolio
- 4.5.5 The Wellcome Foundation Recent Developments
- 4.6 Chongqing Huapont Pharmaceutical
- 4.6.1 Chongqing Huapont Pharmaceutical Company Information
- 4.6.2 Chongqing Huapont Pharmaceutical Business Overview
- 4.6.3 Chongqing Huapont Pharmaceutical Acrivastine Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chongqing Huapont Pharmaceutical Acrivastine Capsules Product Portfolio
- 4.6.5 Chongqing Huapont Pharmaceutical Recent Developments
5 Global Acrivastine Capsules Market Scenario by Region
- 5.1 Global Acrivastine Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Acrivastine Capsules Sales by Region: 2021-2032
- 5.2.1 Global Acrivastine Capsules Sales by Region: 2021-2026
- 5.2.2 Global Acrivastine Capsules Sales by Region: 2027-2032
- 5.3 Global Acrivastine Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Acrivastine Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Acrivastine Capsules Revenue by Region: 2027-2032
- 5.4 North America Acrivastine Capsules Market Facts & Figures by Country
- 5.4.1 North America Acrivastine Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Acrivastine Capsules Sales by Country (2021-2032)
- 5.4.3 North America Acrivastine Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Acrivastine Capsules Market Facts & Figures by Country
- 5.5.1 Europe Acrivastine Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Acrivastine Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Acrivastine Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Acrivastine Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Acrivastine Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Acrivastine Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Acrivastine Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Acrivastine Capsules Market Facts & Figures by Country
- 5.7.1 South America Acrivastine Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Acrivastine Capsules Sales by Country (2021-2032)
- 5.7.3 South America Acrivastine Capsules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Acrivastine Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Acrivastine Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Acrivastine Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Acrivastine Capsules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Acrivastine Capsules Sales by Type (2021-2032)
- 6.1.1 Global Acrivastine Capsules Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Acrivastine Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Acrivastine Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Acrivastine Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Acrivastine Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Acrivastine Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Acrivastine Capsules Sales by Application (2021-2032)
- 7.1.1 Global Acrivastine Capsules Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Acrivastine Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Acrivastine Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Acrivastine Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Acrivastine Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Acrivastine Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Acrivastine Capsules Value Chain Analysis
- 8.1.1 Acrivastine Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Acrivastine Capsules Production Mode & Process
- 8.2 Acrivastine Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Acrivastine Capsules Distributors
- 8.2.3 Acrivastine Capsules Customers
9 Global Acrivastine Capsules Analyzing Market Dynamics
- 9.1 Acrivastine Capsules Industry Trends
- 9.2 Acrivastine Capsules Industry Drivers
- 9.3 Acrivastine Capsules Industry Opportunities and Challenges
- 9.4 Acrivastine Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst